Literature DB >> 31237362

Central somatostatin signaling and regulation of food intake.

Andreas Stengel1,2, Yvette Taché3,4.   

Abstract

The discovery of somatostatin (SST) in the hypothalamus implicated the peptide in the inhibition of growth hormone release. However, as observed for numerous neuropeptides, SST was neither restricted to this one brain site nor to this one function. Subsequent studies established a widespread but specific expression of SST in the central nervous system of rodents and humans along with the expression patterns of five receptors (sst1-5 ). Among biological actions, the activation of central SST signaling induced a robust stimulation of food and water intake, which is mediated by the sst2 as assessed using selective sst agonists. The past years have witnessed the identification of brain SST circuitries involved using chemogenetic and optogenetic approaches and further established a physiological orexigenic role of brain SST signaling. The present review will discuss these recent findings.
© 2019 New York Academy of Sciences.

Entities:  

Keywords:  brain-gut; drinking; feeding; food intake microstructure; homeostasis

Mesh:

Substances:

Year:  2019        PMID: 31237362      PMCID: PMC6834873          DOI: 10.1111/nyas.14178

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  79 in total

Review 1.  Characterisation of somatostatin sst2 receptor splice variants.

Authors:  S L Cole; M Schindler
Journal:  J Physiol Paris       Date:  2000 May-Aug

2.  The oncogenic role of the spliced somatostatin receptor sst5TMD4 variant in prostate cancer.

Authors:  Daniel Hormaechea-Agulla; Juan M Jiménez-Vacas; Enrique Gómez-Gómez; Fernando L-López; Julia Carrasco-Valiente; José Valero-Rosa; María M Moreno; Rafael Sánchez-Sánchez; Rosa Ortega-Salas; Francisco Gracia-Navarro; Michael D Culler; Alejandro Ibáñez-Costa; Manuel D Gahete; María J Requena; Justo P Castaño; Raúl M Luque
Journal:  FASEB J       Date:  2017-07-13       Impact factor: 5.191

3.  Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval.

Authors:  Eva M Fekete; Koki Inoue; Yu Zhao; Jean E Rivier; Wylie W Vale; Attila Szücs; George F Koob; Eric P Zorrilla
Journal:  Neuropsychopharmacology       Date:  2006-10-04       Impact factor: 7.853

4.  Circadian organization of food intake and meal patterns in the rat.

Authors:  A M Rosenwasser; Z Boulos; M Terman
Journal:  Physiol Behav       Date:  1981-07

5.  Diurnal variations and sleep deprivation-induced changes in rat hypothalamic GHRH and somatostatin contents.

Authors:  J Gardi; F Obál; J Fang; J Zhang; J M Krueger
Journal:  Am J Physiol       Date:  1999-11

Review 6.  Hypothalamic peptides: central nervous system control of visceral functions.

Authors:  M Brown; Y Taché
Journal:  Fed Proc       Date:  1981-09

7.  Expression and localisation of somatostatin receptor subtypes sst1-sst5 in areas of the rat medulla oblongata involved in autonomic regulation.

Authors:  Emma J Spary; Azhar Maqbool; Trevor F C Batten
Journal:  J Chem Neuroanat       Date:  2007-06-27       Impact factor: 3.052

8.  Orexin-1 receptor mediates the increased food and water intake induced by intracerebroventricular injection of the stable somatostatin pan-agonist, ODT8-SST in rats.

Authors:  Hiroshi Karasawa; Seiichi Yakabi; Lixin Wang; Yvette Taché
Journal:  Neurosci Lett       Date:  2014-06-07       Impact factor: 3.046

9.  On the fate of centrally administered somatostatin in the rat: massive hypersomatostatinemia resulting from leakage into the peripheral circulation has effects on growth hormone secretion and glucoregulation.

Authors:  G S Tannenbaum; Y C Patel
Journal:  Endocrinology       Date:  1986-05       Impact factor: 4.736

10.  Presence of sst5TMD4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumors.

Authors:  Miguel Sampedro-Núñez; Raúl M Luque; Ana M Ramos-Levi; Manuel D Gahete; Ana Serrano-Somavilla; Alicia Villa-Osaba; Magdalena Adrados; Alejandro Ibáñez-Costa; Elena Martín-Pérez; Michael D Culler; Mónica Marazuela; Justo P Castaño
Journal:  Oncotarget       Date:  2016-02-09
View more
  5 in total

Review 1.  A role for the neuropeptide somatostatin in the neurobiology of behaviors associated with substances abuse and affective disorders.

Authors:  Stacey L Robinson; Todd E Thiele
Journal:  Neuropharmacology       Date:  2020-02-03       Impact factor: 5.250

2.  Somatostatin 1.1 contributes to the innate exploration of zebrafish larva.

Authors:  Feng B Quan; Laura Desban; Olivier Mirat; Maxime Kermarquer; Julian Roussel; Fanny Koëth; Hugo Marnas; Lydia Djenoune; François-Xavier Lejeune; Hervé Tostivint; Claire Wyart
Journal:  Sci Rep       Date:  2020-09-17       Impact factor: 4.379

3.  Identification of an allatostatin C signaling system in mollusc Aplysia.

Authors:  Hui-Min Jiang; Zhe Yang; Ying-Yu Xue; Hui-Ying Wang; Shi-Qi Guo; Ju-Ping Xu; Ya-Dong Li; Ping Fu; Xue-Ying Ding; Ke Yu; Wei-Jia Liu; Guo Zhang; Jian Wang; Hai-Bo Zhou; Abraham J Susswein; Jian Jing
Journal:  Sci Rep       Date:  2022-01-24       Impact factor: 4.379

Review 4.  Role of Somatostatin Signalling in Neuroendocrine Tumours.

Authors:  Olesja Rogoza; Kaspars Megnis; Marija Kudrjavceva; Aija Gerina-Berzina; Vita Rovite
Journal:  Int J Mol Sci       Date:  2022-01-27       Impact factor: 5.923

5.  Novel Drug-Like Somatostatin Receptor 4 Agonists are Potential Analgesics for Neuropathic Pain.

Authors:  Boglárka Kántás; Rita Börzsei; Éva Szőke; Péter Bánhegyi; Ádám Horváth; Ágnes Hunyady; Éva Borbély; Csaba Hetényi; Erika Pintér; Zsuzsanna Helyes
Journal:  Int J Mol Sci       Date:  2019-12-11       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.